Skip to content
Home/Companies/Biotech/Revel Pharmaceuticals
RP

Revel Pharmaceuticals

Biotech·United States·Active·6yr hold

Revel Pharmaceuticals is a biotech company, headquartered in United States.

Entry
2020
Hold
6yr
Status
Active
Est. EV
–

Who owns Revel Pharmaceuticals?

Revel Pharmaceuticals is currently owned by KIZOO Technology Capital through KIZOO Evergreen (Balance Sheet) (2007 vintage), since 2020.

Hand-verified · updated 2026-07-03

KIZOO Technology Capital
Investor
KIZOO Technology Capital
KIZOO Evergreen (Balance Sheet) · 2007 · Evergreen

Key facts

HQUnited States
SectorBiotech
StatusActive

More from KIZOO Evergreen (Balance Sheet)

Other portfolio companies in the same fund.

Reservoir Neuroscience
Active
BiotechUnited States· 2024
MoglingBio
Active
BiotechGermany· 2022
Cellvie
Active
BiotechSwitzerland· 2021
Elastrin Therapeutics
Active
BiotechUnited States· 2021
Cyclarity Therapeutics
Active
BiotechUnited States· 2019
MAIA Biotechnology
Exited 2022
BiotechUnited States· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings